Adalimumab Therapy is Effective and Well Tolerated in AS, RA, and PsA Patients with a History of Insufficient Response or Intolerance to Other Anti—TNF Therapies

Article Information

DOI 
http://dx.doi.org/10.1177/155989770800800513
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2008 MD Conference Express

Author Information

  1. Phil Vinall
  1. Gerd-Rüdiger Burmester, MD
    1. Charité-University Medicine, Berlin, Germany
View Full Text

Article usage

AbstractFullPDF
Apr 2015600
May 2015800
Jun 2015100
Jul 2015111
Aug 2015100
Oct 2015233
Total1944

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Adalimumab Therapy is Effective and Well Tolerated in AS, RA, and PsA Patients with a History of Insufficient Response or Intolerance to Other Anti—TNF Therapies
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Inflammatory Disorders Clinical Trials
Rheumatoid Arthritis
Arthritis